Lv6
2180 积分 2024-11-03 加入
The Treatment of Marginal Zone Lymphoma
24天前
已完结
Multifocal soft tissue Langerhans’ cell histiocytosis treated with PET-CT based conformal radiotherapy
29天前
已完结
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
1个月前
已完结
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
1个月前
已完结
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
1个月前
已完结
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
1个月前
已完结
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
1个月前
已完结
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
1个月前
已完结
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
1个月前
已完结
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
1个月前
已完结
皖公网安备34019202002308
